Philippe Saas is Professor of immunology and cell Therapy at the University of Franche-Comté, Besançon, France. Professor Saas is the Current Director of the EFS-BFC (French Blood Agency) Research Department. He is also Director of an INSERM research unit called “Host-Graft-Tumor Interaction & Cell and Gene Engineering,” where he leads a research team investigating tolerance and inflammation in transplantation and transfusion. During his postdoc fellowship at the University of Geneva (from 1995 to 1998, Switzerland), he studied immune responses against tumors of the central nervous system (glioblastoma). He obtained his Ph.D. degree at the Metz University (France) in 1997 where he studied the interactions of xenobiotics with the immune system, notably T cells. He is a Member of several international professional societies including the European Cell Death Organization (ECDO), the American Association of Immunologists (AAI), and the American Society of Hematology ASH and a Member of Faculty of F1000 for Immunomodulation (http://F1000.com). The research unit headed by Professor Saas mainly focuses on i) the evaluation of donor-recipient interactions in the setting of kidney or hematopoietic cell (HC) transplantation and ii) the development of cell-based and ex vivo gene therapy approaches to modulate donor-recipient interactions and thus increase overall transplantation efficacy. He studies the interactions between the immune system and apoptotic cells in order to propose apoptotic cell infusion as an alternative cell-based therapy approaches.
Biography Updated on 14 October 2011